CAS RN: 1469882-57-2

(1R,2R)-2-[(4S,11bR)-3,5-Dihydro-4H-dinaphtho[2,1-c:1′,2′-e]phosphepin-4-yl]-1,2-diphenylethanamine, min. 97%

Product Availability

Choose a grade to view its available package options.

5 package records2 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251220 100mg Out of stock Inquiry
Batchno.20250117 1g Out of stock Inquiry
Batchno.20260105 250mg In stock Shenzhen, Tianjin, Chengdu Inquiry
Batchno.20260414 50mg In stock Shanghai Inquiry
Batchno.20260507 50mg / 100mg / 250mg / 1g Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS1469882-57-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1469882-57-2 / (1R,2R)-1,2-diphenyl-2-(13-phosphapentacyclo[13.8.0.02,11.03,8.018,23]tricosa-1(15),2(11),3,5,7,9,16,18,20,22-decaen-13-yl)ethanamine

Standard CAS: 1469882-57-2 Multi CAS: No

Basic Information

CAS
1469882-57-2
Multi CAS
No
Molecular Formula
C36H30NP
Molecular Weight
507.600000
Exact Mass
507.211587
SMILES
C1C2=C(C3=CC=CC=C3C=C2)C4=C(CP1[C@H](C5=CC=CC=C5)[C@@H](C6=CC=CC=C6)N)C=CC7=CC=CC=C74
InChI
InChI=1S/C36H30NP/c37-35(27-13-3-1-4-14-27)36(28-15-5-2-6-16-28)38-23-29-21-19-25-11-7-9-17-31(25)33(29)34-30(24-38)22-20-26-12-8-10-18-32(26)34/h1-22,35-36H,23-24,37H2/t35-,36-/m1/s1
InChIKey
YHBAPPMVVCHAQC-LQFQNGICSA-N

Computed Properties

Structural Parameters

Heavy atom count
38
Aromatic heavy atom count
32
Fraction Csp3
0.11
Rotatable bonds
4
H-bond acceptors
1
H-bond donors
1
Molar refractivity
163.77
TPSA
26.02

LogP / Solubility

WLOGP
9.6
MLOGP
8.48
XLogP3
7.2
Consensus LogP
8.43
Log S (ESOL)
-9.39
Class (ESOL)
Insoluble
Log S (Ali)
-10.65
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-11.4
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
1

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7

Get In Touch

Contact Us